Pain Management Devices And Therapies Market Research Explores Growth Within A $7.37 Billion Opportunity

The pain management devices and therapies sector is on track for substantial growth in the coming years. With advancements in technology and increasing demand for effective pain relief, this market is set to undergo notable expansion by 2030. Let's explore the current market size, leading companies, key trends, and major segments shaping this evolving industry.

Projected Growth and Size of the Pain Management Devices and Therapies Market
The market for pain management devices and therapies is anticipated to reach $7.38 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.4%. This upward trend is driven by factors such as the aging global population, advancements in neurostimulation technologies, increasing demand for long-term pain management solutions, growth in outpatient pain clinics, and rising healthcare spending. Additionally, the forecast period is expected to witness trends like wider adoption of neurostimulation therapies, greater use of non-opioid pain treatments, expansion in implantable pain management devices, heightened demand for chronic pain care, and a move toward minimally invasive pain relief procedures.

Download a free sample of the Pain Management Devices And Therapies market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2490&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Top Companies Influencing the Pain Management Devices and Therapies Market
The industry landscape is shaped by several key players, including Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, Baxter International Inc., Johnson & Johnson, Smiths Medical Inc., Becton dic*kinson and Company, DJO Global Inc., B Braun Melsungen AG, Neurotech Na, Nevro Corp, NeuroMetrix Inc, Medovex Corporation, Halyard Health Inc, Flowonix Medical Inc, Pain Management Technologies Inc, Avanos Medical Inc, Stimwave Technologies LLC, Omron Healthcare Inc., Stryker Corporation, ICU Medical Inc., Nipro Corporation, Zynex Medical Inc., Saluda Medical Pty Ltd., and SPR Therapeutics.

A notable development occurred in April 2025 when Globus Medical Inc., a US-based musculoskeletal technology firm, acquired Nevro Corp. for an undisclosed sum. This acquisition aims to boost Globus Medical's market presence by leveraging Nevro's unique high-frequency spinal cord stimulation technology, thereby expanding treatment options for patients dealing with chronic pain. Nevro Corp. specializes in innovative spinal cord stimulation systems designed for chronic pain relief.

View the full Pain Management Devices And Therapies market report:
https://www.thebusinessresearchcompany.com/report/pain-management-devices-and-therapies-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Emerging Trends Driving Innovation in Pain Management Devices and Therapies
Leading companies in the pain management space are dedicating efforts to the development of advanced neuromodulation technologies, including closed-loop spinal cord stimulation systems. These systems provide personalized pain treatment by delivering electrical pulses to the spinal cord while simultaneously monitoring neural responses, allowing real-time adjustments for consistent pain relief.

For example, in April 2024, Medtronic plc received FDA approval for its Inceptiv closed-loop rechargeable spinal cord stimulator designed for chronic pain management. This fully implantable device uses proprietary sensing technology to capture biological signals, enabling personalized, data-driven therapy. Its automatic adjustment feature optimizes stimulation in real time, maintaining a steady therapeutic dose without requiring patient intervention.

Breaking Down the Key Segments in the Pain Management Devices and Therapies Market
The market is segmented into several categories to better understand its dynamics:

1) By Product Type:
- Electrical Stimulation Devices
- Thermal Therapy Devices
- Minimally Invasive Devices
- Injection and Infusion Systems
- Ultrasound and Laser Therapy Devices
- Other Product Types

2) By Therapy Type:
- Pharmacologic Therapies
- Non-Pharmacologic Therapies
- Interventional or Surgical Therapies

3) By Pain Indication:
- Chronic Pain
- Acute Pain
- Other Pain Conditions

4) By End User:
- Hospitals
- Ambulatory Surgical Centers
- Pain Clinics
- Rehabilitation Centers
- Home Healthcare
- Specialty Clinics or Outpatient Facilities

The product type category further breaks down into subcategories such as spinal cord stimulators, transcutaneous electrical nerve stimulation (TENS), interferential current therapy devices, peripheral nerve stimulators, and deep brain stimulation devices under electrical stimulation. Thermal therapy devices include cryotherapy units and heat therapy pads and wraps, while minimally invasive devices feature radiofrequency ablation devices, epidural catheters, intrathecal drug delivery systems, and neuroablative devices. Injection and infusion systems incorporate pain infusion pumps and needle-based injectors. Ultrasound and laser therapy devices cover therapeutic ultrasound and low-level laser therapy (LLLT). Other products include acupuncture stimulators and biofeedback and rehabilitation devices.

New additions to our 2026 reports:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.